MRK vs COR
By Alex · Tickerpine
Merck & Co., Inc. vs Cencora, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | COR |
|---|---|---|
| Price | $148.78 | $306.92 |
| Market cap | $367.07B | $58.57B |
| P/E ratio | 119.0 | 22.8 |
| ROE | 6.96% | 96.87% |
| Profit margin | 4.77% | 0.79% |
| Revenue growth | 5.10% | 5.10% |
| Dividend yield | 2.29% | 0.78% |
| Beta | 0.23 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs COR in plain English
- MRK is the bigger company — about 6.3× the market cap of COR.
- COR is cheaper on earnings (P/E 22.8 vs 119.0).
- COR earns a higher return on equity (97% vs 7%).
- COR is growing revenue faster (5% vs 5%).
- MRK has the higher dividend yield (2.29% vs 0.78%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
COR return calculator
See what $1,000 in Cencora, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.